Seattle, WA · Founded 2008 · Privately Held (backing)
Developer of a synthetic biology technology designed to create new designer proteins and enzymes with less risk. Arzeda is based in Seattle, WA and was founded in 2008. It was valued at $150 million at its later-stage round in Dec 2025, the last priced event on record. It has raised $109 million across 6 recorded rounds; the latest was a $4.5 million seed round in Aug 2025.
PMV mark · valuation
$149.5M
Oct 2026
Priced at
its later-stage round
Dec 2025
Total raised
$109.2M
Last round
Seed Round
Aug 2025
Team — not yet on record
No current team members for Arzeda are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Arzeda with a free account
·The complete investor list: 25 names
·Watch Arzeda: the Monday email on marks, rounds and moves
